Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
TFPI encodes a protease inhibitor that regulates the tissue factor (TF)-dependent pathway of blood coagulation. Zusätzlich bieten wir Ihnen TFPI Antikörper (203) und TFPI Proteine (34) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 98 products:
Mouse (Murine) TFPI ELISA Kit für Sandwich ELISA - ABIN415387
Walter, Steinwede, Aly, Reinheckel, Bohling, Maus, Ehlers: Cathepsin G in Experimental Tuberculosis: Relevance for Antibacterial Protection and Potential for Immunotherapy. in Journal of immunology (Baltimore, Md. : 1950) 2015
Show all 3 Pubmed References
Human TFPI ELISA Kit für Sandwich ELISA - ABIN1672813
Xu, Qin, Zhou, Tu, Bi, Li, Fan, Zhang: Tissue factor pathway inhibitor-2 inhibits the growth and invasion of hepatocellular carcinoma cells and is inactivated in human hepatocellular carcinoma. in Oncology letters 2012
Human TFPI ELISA Kit für Sandwich ELISA - ABIN416737
Farid, Mohammed, Afifi, Beltagi: Tissue factor pathway inhibitor in paediatric patients with nephrotic syndrome. in SAJCH : the South African journal of child health 2012
endogenous TFPI from vascular smooth muscle cells inhibited ferric chloride-induced arterial thrombosis without causing hemostatic effects
TFPI-1 interacts with AMOT (zeige AMOT ELISA Kits), which led to a decrease in the phosphorylation of YAP (zeige YAP1 ELISA Kits) and further increased the genes expression of the proliferation and migration involved. Our results further confirmed that atherosclerosis was a localized disease.
Results suggest that endothelial cell-anchored TFPI controls lung tumor metastasis, and does so largely through the inhibition of local TF-induced thrombin (zeige F2 ELISA Kits) generation and the regulation of the lung microenvironment in mice.
Data argue against an important role for endogenous TFPI in the antibacterial, inflammatory and procoagulant response during pneumococcal pneumonia.
TFPI has an anti-proliferative role in TNF-alpha (zeige TNF ELISA Kits) stimulated-VSMCs at least partly by interfering with the MCP-3 (zeige CCL7 ELISA Kits)/CCR2 (zeige CCR2 ELISA Kits) pathway and then via suppression of the ERK1/2 (zeige MAPK1/3 ELISA Kits) and PI3K/AKT (zeige AKT1 ELISA Kits) signaling pathways
Results demonstrate that TFPI physiologically modulates thrombin (zeige F2 ELISA Kits)-dependent platelet activation in a manner that is required for successful embryonic development
Tissue factor (zeige F3 ELISA Kits) plays a hitherto unreported role in the generation of macrophage migratory inhibitory factor by vascular smooth muscle cells in atherosclerosis-prone ApoE (zeige APOE ELISA Kits)(-/-) mice.
The increased plasmin (zeige PLG ELISA Kits) generation during the early stages of sepsis could cleave/inactivate TFPI and thus lead to thrombotic complications.
structural features within residues of the 39-loop contribute to the resistance of FIXa (zeige ETFB ELISA Kits) to inhibition by plasma inhibitors ZPI (zeige SERPINA10 ELISA Kits) and TFPI.
PAK1 (zeige PAK1 ELISA Kits) negatively regulates the expression of TFPI and additionally contributes to increased TF activity.
Patients with early onset preeclampsia are characterised by an attenuated coagulation response characterised by reduced thrombin (zeige F2 ELISA Kits) generation stimulated by low-dose TF and elevated plasma TFPI activity.
Developed functional protein S assays that measure both the activated protein C (zeige PROC ELISA Kits)- and TFPI-cofactor activities of protein S in plasma, which are hardly if at all affected by the FV Leiden mutation.
These data indicate that both isoforms of TFPI are present in advanced plaques and that anti-inflammatory M2 macrophages may be a potential source of TFPI.
Among the various candidate genes involved in acute rejection, CD47 (zeige CD47 ELISA Kits) inhibits monocyte/macrophage-mediated phagocytosis by identifying the CD47 (zeige CD47 ELISA Kits) signal regulatory protein alpha (SIRP (zeige SIRPA ELISA Kits)-alpha) as self/non-self. Tissue factor pathway inhibitor (TFPI) is involved in the regulation of the coagulation pathway and is able to bind to another ligand of CD47 (zeige CD47 ELISA Kits), thrombospondin-1 (TSP-1 (zeige THBS1 ELISA Kits)).
Tissue Factor Pathway Inhibitor Gene Polymorphism is associated with response to therapy in Colorectal Cancer.
For the first time, we show that a TFPI variant is significantly associated with fibrinogen levels and risk of coronary artery disease.
miR (zeige MLXIP ELISA Kits)-27a/b and miR (zeige MLXIP ELISA Kits)-494 regulate TFPIalpha expression; there may be a role of these miRNAs in the estrogen-mediated downregulation of TFPIalpha
Genetic variations of the TFPI genes seem to be related with coronary artery disease, which likely cooperate with metabolic risk factor (diabetes mellitus) and play critical roles in the pathogenesis of coronary artery disease in Han Chinese.
Cleavage of FV at Arg(1545) , which abolishes the anticoagulant properties of FV and commits FV to the procoagulant pathway, is inhibited by binding of the TFPIalpha C-terminus to the FV acidic region
The aim of this study was to evaluate the concentration of TF and its inhibitor TFPI in blood plasma, the impact of traditional and non-traditional cardiovascular risk factors on their concentration and the impact of both markers of haemostasis on the severity of subclinical atherosclerosis.
Upregulated TF expression and increased plasma TF level during reperfusion period, reduced plasma TFPI-1 level during reperfusion period.
This gene encodes a protease inhibitor that regulates the tissue factor (TF)-dependent pathway of blood coagulation. The coagulation process initiates with the formation of a factor VIIa-TF complex, which proteolytically activates additional proteases (factors IX and X) and ultimately leads to the formation of a fibrin clot. The product of this gene inhibits the activated factor X and VIIa-TF proteases in an autoregulatory loop. The encoded protein is glycosylated and predominantly found in the vascular endothelium and plasma in both free forms and complexed with plasma lipoproteins. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been confirmed.
extrinsic pathway inhibitor
, lipoprotein-associated coagulation inhibitor
, uncharacterized protein LOC100155068
, tissue factor pathway inhibitor